When marketing and science intersect: do patients with MS benefit?
Lublin
Fred D
FD
Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Mount Sinai Medical Center, New York, NY 10029-6574, USA. Fred.Lublin@mssm.edu
D006801:Humans; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
D016899:Interferon-beta; D000068556:Interferon beta-1a